Publication | Open Access

Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation

Acute Lung InjuryInflammationAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineImmunologyChronic InflammationPulmonary PharmacologySelective Brd4 InhibitorsImmunotherapyPharmacologyNovel TherapyDrug Discovery